Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf

November 6, 2025 4:01 PM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced that it will be exhibiting at MEDICA 2025 in Düsseldorf, Germany, November 17-20, 2025.MEDICA is one of the...

Read more

NewEra Protect Reviews (URGENT ALERT) Doctor Reveals Truth Behind This Kidney & Bladder Support Breakthrough In 2025

November 6, 2025 3:55 PM

In a surprising medical revelation this year, researchers have confirmed what many women over 40 suspected for years: bladder leakage and pelvic discomfort often begin not in the bladder itself, but in the kidneys. The kidneys act as the filtration system that keeps blood clean, muscles nourished, and the pelvic floor resilient. When toxin buildup disrupts this process, women begin to experience progressive muscle weakening, urinary urgency, and...

Read more

E&I Cooperative Services Awards Cenmed Enterprises Contract for Medical, Laboratory, and Sports Medicine Products

November 6, 2025 3:00 PM

E&I Cooperative Services (E&I), the only member-owned, nonprofit sourcing cooperative focused exclusively on education, has awarded a competitively solicited contract to Cenmed Enterprises for Medical-Surgical Products, Pharmaceuticals, Vaccines, Sports Medicine/Athletics Products, and Related Services (Contract CR001455), eandi.cenmed.com.Effective September 1, 2025 through August 31, 2029, the agreement gives E&I's education and healthcare...

Read more

Venture Medical Issues Statement on CMS 2026 Physician Fee Schedule Final Rule

November 6, 2025 2:25 PM

Venture Medical, LLC, today issued the following statement regarding the Centers for Medicare & Medicaid Services' (CMS) Calendar Year 2026 Physician Fee Schedule (PFS) Final Rule, which introduces a new framework for the Medicare reimbursement of skin substitutes."CMS's final rule represents a defining moment for the wound care industry," said John Schroeder, CEO of Venture Medical. "As one of the nation's leading distributors of advanced wound...

Read more

Omnix Medical and Prevail Partners, LLC Announce Strategic and Financial Partnership

November 6, 2025 2:00 PM

Omnix Medical Ltd., P.C. ("Omnix Medical") and Prevail Partners, LLC ("Prevail Partners") join in a strategic partnership that will efficiently and economically drive the clinical advancement of Omnix Medical's pipeline of first-in-class, leading edge anti-infectives. The lead compound OMN6 is well positioned to become a first-line treatment for severe or life-threatening infections involving multidrug- and carbapenem-resistant Acinetobacter...

Read more

Gluco Armor Reviews (URGENT REPORT) Doctor Reveals Truth Behind This Blood-Sugar Support Formula In 2025

November 6, 2025 12:45 PM

In an era where blood-sugar supplements flood the market with exaggerated promises, Gluco Armor stands out for an unusual reason, it has caught the attention of medical professionals who are publicly weighing in on its legitimacy. In this 2025 investigative review, we analyzed Verified Consumer Reports, Clinical-Style Mechanisms Here, refund policies, and expert commentary to determine whether Gluco Armor's claims about metabolic support...

Read more

Record Earnings for Gubra; Revised Outlook for the CRO Business

November 6, 2025 11:30 AM

Revenue and earnings for Gubra (CPH:GUBRA) reached record-high levels in the first nine months of 2025. Group revenue and adjusted EBIT amounted to DKK 2.6 billion and DKK 2.3 billion, respectively, compared with DKK 203 million and a small loss in the same period of 2024. The strong increase was primarily driven by the outlicensing agreement with AbbVie in the Discovery & Partnerships segment. In Gubra's CRO business, revenue for the first nine...

Read more

World Series Spotlights Need for Wearable Ultrasound System to Accelerate Recovery, Treat Injuries

November 6, 2025 11:06 AM

As baseball's thrilling World Series has shown, pitchers and position players are maximizing their efforts on short rest and under great pressure. ZetrOZ Systems' sustained acoustic medicine (sam®) technology, already in wide use across baseball and other professional sports, helps pitchers and position players recover faster from games and workouts.Repeated overhand throwing at peak effort is a main cause of baseball's shoulder injuries, such...

Read more

The Longevity Center FL Explores the Benefits of EBOO Therapy for Oxygenating and Detoxifying the Blood

November 6, 2025 10:00 AM

The Longevity Center FL has adopted Extracorporeal Blood Oxygenation and Ozonation (EBOO) Therapy as part of its comprehensive approach to regenerative medicine and detoxification. This advanced treatment represents a significant evolution in oxygenation-based therapies, offering patients an option that combines scientific innovation with holistic wellness principles.Understanding EBOO TherapyEBOO Therapy is a medical procedure that oxygenates...

Read more

Medical Care Technologies (OTC Pink:MDCE) Enters Final Phase of Testing for First Consumer App, With Beta Launch Slated for Q4 2025

November 6, 2025 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE), led by CEO Marshall Perkins, is thrilled to announce that the company is entering the final phase of testing for its highly anticipated first consumer application. This marks a major milestone as the company gears up for a beta launch in Q4 2025. The upcoming beta release not only signifies our commitment to innovation but also paves the way for immediate revenue potential upon launch, reflecting...

Read more

Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin

November 6, 2025 9:00 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today announced its successful participation in the CPHI Frankfurt trade show, the world's largest pharmaceutical event. The Company engaged in numerous strategic discussions with global pharmaceutical companies regarding technical collaboration and licensing opportunities for its lead product...

Read more

REMINDER: Initial Groundbreaking Results of Proof-of-Concept Study of Jaguar Health's Crofelemer for Treatment of Pediatric Intestinal Failure to be Presented November 8, 2025 at North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) Annual Meeting

November 6, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today issued a reminder that an abstract describing partial results of the independent and ongoing investigator-initiated trial (IIT) of crofelemer in the UAE for treatment of pediatric intestinal failure, which includes patients with intestinal failure due to microvillus inclusion disease (MVID) and short bowel syndrome (SBS-IF), will be presented this coming...

Read more

Encouraging Results from a First-in-Human Phase 1 Clinical Trial of IAVI's Lassa Vaccine Candidate Published in New England Journal of Medicine

November 6, 2025 9:00 AM

Findings from a first-in-human, Phase 1 clinical trial of IAVI's Lassa virus (LASV) vaccine candidate published today in the New England Journal of Medicine demonstrate that one dose of the vaccine elicits robust and long-lasting immune responses and has an acceptable safety profile. IAVI, the study sponsor, is a nonprofit scientific research organization developing vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases...

Read more

Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid

November 6, 2025 8:45 AM

Entero Therapeutics, Inc. (NASDAQ:ENTO) ("ENTO" or the "Company"), the parent company of Grid AI, announced today the signing of a Letter of Intent to integrate the LV Grid engineering team and related intellectual property into Grid AI.The company believes the addition of LV Grid marks a critical step in Grid AI's strategy to capture a leading position in the rapidly expanding AI data-center energy-orchestration market. Under the proposed...

Read more

VSee Engages Philippine Health Leaders and Former VP Robredo in Southeast Asia expansion effort

November 6, 2025 8:17 AM

VSee Health, Inc. (Nasdaq:VSEE), a leading provider of secure, AI-powered telehealth technology, joined the Philippine Tuberculosis Society and former Philippine Vice President Leni Robredo (currently mayor of Naga City) to discuss opportunities to enhance healthcare delivery in Naga City through digital health innovation.This initial discussion highlighted key healthcare challenges in Naga City, such as prenatal check-up rates-only 44% compared...

Read more

Aptevo Therapeutics Reports 3Q25 Financial Results And Provides A Business Update

November 6, 2025 8:05 AM

Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology Company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, today reported financial results for the quarter ended September 30, 2025, and provided a business update.Third Quarter Highlights89% remission* reported among evaluable frontline AML patients across two trials treated with mipletamig in...

Read more

Becker Plastic Surgery Shares Insights on the Rise of Masculine Facial Rejuvenation

November 6, 2025 8:00 AM

More men than ever are turning to facial rejuvenation to look rested and confident while maintaining their natural appearance. At Becker Plastic Surgery, serving patients in Princeton, New Jersey, and Philadelphia, Pennsylvania, a team of board-certified facial plastic surgeons and aesthetic injectors offers individualized surgical and nonsurgical options designed specifically for men's facial structure and goals.A Growing Interest in Subtle,...

Read more

Moderna Reports Third Quarter 2025 Financial Results and Provides Business Updates

November 6, 2025 7:00 AM

Moderna, Inc. (NASDAQ:MRNA) today reported financial results and provided business updates for the third quarter of 2025."We delivered strong commercial and financial performance in the third quarter, supported by COVID vaccine sales following the successful launch of mNEXSPIKE and a significant improvement in expected 2025 operating expenses from our ongoing cost-reduction initiatives," said Stéphane Bancel, Chief Executive Officer of Moderna....

Read more

Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential

November 6, 2025 6:30 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic device products for equine and companion animals, today announced that it has earned ISO 13485:2016 certification for its manufacturing and distribution operations in Plymouth, Minnesota and Roswell, Georgia. This milestone further cements Zomedica's commitment to quality, compliance, and global market...

Read more

SlicedHealth Elevates Hospital Contract Intelligence with SlicedIQ

November 6, 2025 6:00 AM

For rural hospitals operating on the thinnest of margins, collecting every dollar earned, as expected and on time, can be the difference between sustainability or eventual closure. But the burden and complexity of securing hospital revenue - dealing with denials and underpayments - can often be more than a community hospital with limited resources can manage alone.SlicedHealth, a technology provider committed to strengthening rural and community...

Read more